Cargando…

Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization

BACKGROUND AND THE PURPOSE OF THE STUDY: Domperidone (DOM) is a dopamine- receptor (D(2)) antagonist, which is widely used in the treatment of motion-sickness. The pharmacokinetic parameters make DOM a suitable candidate for transdermal delivery. The purpose of the present investigation was to devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Madishetti, S.K., Palem, C.R., Gannu, R., Thatipamula, R.P., Panakanti, P.K., Yamsani, M.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304359/
https://www.ncbi.nlm.nih.gov/pubmed/22615620
_version_ 1782226885944541184
author Madishetti, S.K.
Palem, C.R.
Gannu, R.
Thatipamula, R.P.
Panakanti, P.K.
Yamsani, M.R.
author_facet Madishetti, S.K.
Palem, C.R.
Gannu, R.
Thatipamula, R.P.
Panakanti, P.K.
Yamsani, M.R.
author_sort Madishetti, S.K.
collection PubMed
description BACKGROUND AND THE PURPOSE OF THE STUDY: Domperidone (DOM) is a dopamine- receptor (D(2)) antagonist, which is widely used in the treatment of motion-sickness. The pharmacokinetic parameters make DOM a suitable candidate for transdermal delivery. The purpose of the present investigation was to develop transdermal delivery systems for DOM and to evaluate their physicochemical characteristics, in vitro release an ex vivo permeation through rat abdominal skin and their mechanical properties. METHODS: Bilayered matrix type transdermal drug delivery systems (TDDS) of DOM were prepared by film casting technique using hydroxypropyl methyl cellulose as primary and Eudragit RL 100 as secondary layers. Brij-35 was incorporated as a solubilizer, d-limonene and propylene glycol were employed as permeation enhancer and plasticizer respectively. The prepared TDDS were extensively evaluated for in vitro release, moisture absorption, moisture content, water vapor transmission, ex vivo permeation through rat abdominal skin, mechanical properties and stability studies. The physicochemical interaction between DOM and polymers were investigated by Differential Scanning Calorimetry (DSC) and Fourier Transform Infrared Spectroscopy (FTIR). RESULTS: All the formulations exhibited satisfactory physicochemical and mechanical characteristics. The optimized formulation F6 showed maximum cumulative percentage of drug release (90.7%), permeation (6806.64 µg) in 24 hrs, flux (86.02 µg /hr/cm(2)) and permeation coefficient of 0.86x10(−2) cm/hr. Values of tensile strength (4.34 kg/mm(2)) and elastic modulus (5.89 kg/cm(2)) revealed that formulation F6 was strong but not brittle. DSC and FTIR studies showed no evidence of interaction between the drug and polymers. A shelf life of 2 years is predicted for the TDDS. CONCLUSIONS: Domperidone bilayered matrix type transdermal therapeutic systems could be prepared with the required flux and suitable mechanical properties.
format Online
Article
Text
id pubmed-3304359
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-33043592012-05-21 Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization Madishetti, S.K. Palem, C.R. Gannu, R. Thatipamula, R.P. Panakanti, P.K. Yamsani, M.R. Daru Original Article BACKGROUND AND THE PURPOSE OF THE STUDY: Domperidone (DOM) is a dopamine- receptor (D(2)) antagonist, which is widely used in the treatment of motion-sickness. The pharmacokinetic parameters make DOM a suitable candidate for transdermal delivery. The purpose of the present investigation was to develop transdermal delivery systems for DOM and to evaluate their physicochemical characteristics, in vitro release an ex vivo permeation through rat abdominal skin and their mechanical properties. METHODS: Bilayered matrix type transdermal drug delivery systems (TDDS) of DOM were prepared by film casting technique using hydroxypropyl methyl cellulose as primary and Eudragit RL 100 as secondary layers. Brij-35 was incorporated as a solubilizer, d-limonene and propylene glycol were employed as permeation enhancer and plasticizer respectively. The prepared TDDS were extensively evaluated for in vitro release, moisture absorption, moisture content, water vapor transmission, ex vivo permeation through rat abdominal skin, mechanical properties and stability studies. The physicochemical interaction between DOM and polymers were investigated by Differential Scanning Calorimetry (DSC) and Fourier Transform Infrared Spectroscopy (FTIR). RESULTS: All the formulations exhibited satisfactory physicochemical and mechanical characteristics. The optimized formulation F6 showed maximum cumulative percentage of drug release (90.7%), permeation (6806.64 µg) in 24 hrs, flux (86.02 µg /hr/cm(2)) and permeation coefficient of 0.86x10(−2) cm/hr. Values of tensile strength (4.34 kg/mm(2)) and elastic modulus (5.89 kg/cm(2)) revealed that formulation F6 was strong but not brittle. DSC and FTIR studies showed no evidence of interaction between the drug and polymers. A shelf life of 2 years is predicted for the TDDS. CONCLUSIONS: Domperidone bilayered matrix type transdermal therapeutic systems could be prepared with the required flux and suitable mechanical properties. Tehran University of Medical Sciences 2010 /pmc/articles/PMC3304359/ /pubmed/22615620 Text en © 2010 Tehran University of Medical Sciences http://creativecommons.org/licenses/by/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Article
Madishetti, S.K.
Palem, C.R.
Gannu, R.
Thatipamula, R.P.
Panakanti, P.K.
Yamsani, M.R.
Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization
title Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization
title_full Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization
title_fullStr Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization
title_full_unstemmed Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization
title_short Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization
title_sort development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304359/
https://www.ncbi.nlm.nih.gov/pubmed/22615620
work_keys_str_mv AT madishettisk developmentofdomperidonebilayeredmatrixtypetransdermalpatchesphysicochemicalinvitroandexvivocharacterization
AT palemcr developmentofdomperidonebilayeredmatrixtypetransdermalpatchesphysicochemicalinvitroandexvivocharacterization
AT gannur developmentofdomperidonebilayeredmatrixtypetransdermalpatchesphysicochemicalinvitroandexvivocharacterization
AT thatipamularp developmentofdomperidonebilayeredmatrixtypetransdermalpatchesphysicochemicalinvitroandexvivocharacterization
AT panakantipk developmentofdomperidonebilayeredmatrixtypetransdermalpatchesphysicochemicalinvitroandexvivocharacterization
AT yamsanimr developmentofdomperidonebilayeredmatrixtypetransdermalpatchesphysicochemicalinvitroandexvivocharacterization